DNA methylation indicates susceptibility to isoproterenol-induced cardiac pathology and is associated with chromatin states

Circulation Research

Volumn 118, Issue 5, 2016, Pages 786-797

  Chen, Haodong ^a   Orozco, Luz D ^a   Wang, Jessica ^a   Rau, Christoph D ^a   Rubbi, Liudmilla ^a   Ren, Shuxun ^a   Wang, Yibin ^a,b   Pellegrini, Matteo ^a   Lusis, Aldons J ^a   Vondriska, Thomas M ^a,b  

^a Department of Anesthesiology and Perioperative Medicine ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chromatin; DNA methylation; Epigenomics; Genetics; Heart failure

Indexed keywords

DNA; ISOPRENALINE; CARDIOTONIC AGENT; CHROMATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; GENE EXPRESSION; GENETIC ASSOCIATION; HEART DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DISEASE PREDISPOSITION; FEMALE; GENETICS; HEART FAILURE; PATHOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALS; CARDIOTONIC AGENTS; CHROMATIN; CPG ISLANDS; DISEASE SUSCEPTIBILITY; DNA METHYLATION; FEMALE; HEART FAILURE; ISOPROTERENOL; MICE; MICE, INBRED BALB C; SPECIES SPECIFICITY;

EID: 84954453092     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.305298     Document Type: Article

References (41)

1. Lee DS, Pencina MJ, Benjamin EJ, Wang TJ, Levy D, O'Donnell CJ, Nam BH, Larson MG, D'Agostino RB, Vasan RS. Association of parental heart failure with risk of heart failure in offspring. N Engl J Med. 2006;355:138-147. doi: 10.1056/NEJMoa052948.
2. Dorn GW 2nd. Genetics of common forms of heart failure. Curr Opin Cardiol. 2011;26:204-208. doi: 10.1097/HCO.0b013e328345d336.
3. Marian AJ, Belmont J. Strategic approaches to unraveling genetic causes of cardiovascular diseases. Circ Res. 2011;108:1252-1269. doi: 10.1161/CIRCRESAHA.110.236067.
4. Rosa-Garrido M, Karbassi E, Monte E, Vondriska TM. Regulation of chro-matin structure in the cardiovascular system. Circ J. 2013;77:1389-1398.
5. Rivera CM, Ren B. Mapping human epigenomes. Cell. 2013;155:39-55. doi: 10.1016/j.cell.2013.09.011.
6. Wu H, Zhang Y. Reversing DNA methylation: mechanisms, genom-ics, and biological functions. Cell. 2014;156:45-68. doi: 10.1016/j. cell.2013.12.019.
7. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13:484-492. doi: 10.1038/nrg3230.
8. Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA de-methylation. Nature. 2013;502:472-479. doi: 10.1038/nature12750.
9. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22:4632-4642. doi: 10.1200/JCO.2004.07.151.
10. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21:5427-5440. doi: 10.1038/sj.onc.1205600.
11. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA. 1999;96:8681-8686.
12. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell. 2003;4:121-131.
13. Noushmehr H, Weisenberger DJ, Diefes K, et al; Cancer Genome Atlas Research Network. Identifcation of a CpG island methylator phenotype that defnes a distinct subgroup of glioma. Cancer Cell. 2010;17:510-522. doi: 10.1016/j.ccr.2010.03.017.
14. Campbell RM, Tummino PJ. Cancer epigenetics drug discovery and development: the challenge of hitting the mark. J Clin Invest. 2014;124:64-69. doi: 10.1172/JCI71605.
15. Koczor CA, Lee EK, Torres RA, Boyd A, Vega JD, Uppal K, Yuan F, Fields EJ, Samarel AM, Lewis W. Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis. Physiol Genomics. 2013;45:597-605. doi: 10.1152/physiolgenomics.00013.2013.
16. Haas J, Frese KS, Park YJ, et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med. 2013;5:413-429. doi: 10.1002/emmm.201201553.
17. Movassagh M, Choy MK, Goddard M, Bennett MR, Down TA, Foo RS. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One. 2010;5:e8564. doi: 10.1371/journal.pone.0008564.
18. Movassagh M, Choy MK, Knowles DA, Cordeddu L, Haider S, Down T, Siggens L, Vujic A, Simeoni I, Penkett C, Goddard M, Lio P, Bennett MR, Foo RS. Distinct epigenomic features in end-stage failing human hearts. Circulation. 2011;124:2411-2422. doi: 10.1161/CIRCULATIONAHA.111.040071.
19. Turner BM. Environmental sensing by chromatin: an epigenetic contribution to evolutionary change. FEBS Lett. 2011;585:2032-2040. doi: 10.1016/j.febslet.2010.11.041.
20. Orozco LD, Morselli M, Rubbi L, et al. Epigenome-wide association of liver methylation patterns and complex metabolic traits in mice. Cell Metab. 2015;21:905-917. doi: 10.1016/j.cmet.2015.04.025.
21. Jiang L, Zhang J, Wang JJ, et al. Sperm, but not oocyte, DNA methylome is inherited by zebrafsh early embryos. Cell. 2013;153:773-784. doi: 10.1016/j.cell.2013.04.041.
22. Rau CD, Wang J, Avetisyan R, Romay MC, Martin L, Ren S, Wang Y, Lusis AJ. Mapping genetic contributions to cardiac pathology induced by beta-adrenergic stimulation in mice. Circ Cardiovasc Genet. 2015;8:40-49. doi: 10.1161/CIRCGENETICS.113.000732.
23. Zhan L, Huang C, Meng XM, Song Y, Wu XQ, Miu CG, Zhan XS, Li J. Promising roles of mammalian E2Fs in hepatocellular carcinoma. Cell Signal. 2014;26:1075-1081. doi: 10.1016/j.cellsig.2014.01.008.
24. Ramadas N, Rajaraman B, Kuppuswamy AA, Vedantham S. Early growth response-1 (EGR-1)-a key player in myocardial cell injury. Cardiovasc Hematol Agents Med Chem. 2014;12:66-71.
25. Carr SM, Poppy Roworth A, Chan C, La Thangue NB. Post-translational control of transcription factors: methylation ranks highly. FEBS J. 2015;282:4450-4465. doi: 10.1111/febs.13524.
26. Guo Y, Flaherty MP, Wu WJ, Tan W, Zhu X, Li Q, Bolli R. Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1, 074 mice. Basic Res Cardiol. 2012;107:288. doi: 10.1007/s00395-012-0288-y.
27. Ghazalpour A, Rau CD, Farber CR, et al. Hybrid mouse diversity panel: a panel of inbred mouse strains suitable for analysis of complex genetic traits. Mamm Genome. 2012;23:680-692. doi: 10.1007/s00335-012-9411-5.
28. Choi M, Lee J, Le MT, Nguyen DT, Park S, Soundrarajan N, Schachtschneider KM, Kim J, Park JK, Kim JH, Park C. Genome-wide analysis of DNA methylation in pigs using reduced representation bisulfte sequencing. DNA Res. 2015;22:343-355. doi: 10.1093/dnares/dsv017.
29. Schachtschneider KM, Madsen O, Park C, Rund LA, Groenen MA, Schook LB. Adult porcine genome-wide DNA methylation patterns support pigs as a biomedical model. BMC Genomics. 2015;16:743. doi: 10.1186/s12864-015-1938-x.
30. Bell JT, Pai AA, Pickrell JK, Gaffney DJ, Pique-Regi R, Degner JF, Gilad Y, Pritchard JK. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol. 2011;12:R10. doi: 10.1186/gb-2011-12-1-r10.
31. Xie W, Barr CL, Kim A, Yue F, Lee AY, Eubanks J, Dempster EL, Ren B. Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell. 2012;148:816-831. doi: 10.1016/j.cell.2011.12.035.
32. Schilling E, El Chartouni C, Rehli M. Allele-specifc DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res. 2009;19:2028-2035. doi: 10.1101/gr.095562.109.
33. van Eijk KR, de Jong S, Boks MP, Langeveld T, Colas F, Veldink JH, de Kovel CG, Janson E, Strengman E, Langfelder P, Kahn RS, van den Berg LH, Horvath S, Ophoff RA. Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics. 2012;13:636. doi: 10.1186/1471-2164-13-636.
34. Schroeder DI, Blair JD, Lott P, Yu HO, Hong D, Crary F, Ashwood P, Walker C, Korf I, Robinson WP, LaSalle JM. The human placenta meth-ylome. Proc Natl Acad Sci USA. 2013;110:6037-6042. doi: 10.1073/pnas.1215145110.
35. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation. 2003;108:1395-1403. doi: 10.1161/01.CIR.0000085658.98621.49.
36. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol. 2007;293:H1883-H1891. doi: 10.1152/ajpheart.00514.2007.
37. Chen NC, Yang F, Capecci LM, Gu Z, Schafer AI, Durante W, Yang XF, Wang H. Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J. 2010;24:2804-2817. doi: 10.1096/fj.09-143651.
38. Dunn W, Broadhurst D, Deepak S, Buch M, McDowell G, Spasic I, Ellis D, Brooks N, Kell D, Neyses L. Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglu-tarate. Metabolomics. 2007;3:413-426.
39. Ulrey CL, Liu L, Andrews LG, Tollefsbol TO. The impact of metabolism on DNA methylation. Hum Mol Genet. 2005;14(spec no 1):R139-R147. doi: 10.1093/hmg/ddi100.
40. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferas-es. Annu Rev Biochem. 2005;74:481-514. doi: 10.1146/annurev. biochem.74.010904.153721.
41. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. Conversion of 5-methyl-cytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324:930-935. doi: 10.1126/science.1170116.